The CBS/CSE system, which may be regulated by several fatty acids, has been actively investigated in the pathogenesis of NAFLD and has been proposed as a potential therapeutic target for NAFLD [138]. The gene discussed is CTH; the disease is metabolic dysfunction-associated steatotic liver disease.